Story at a glance:
- On Monday January 10th, 2022, the FDA confirmed that Magnesium may reduce the risk of High Blood Pressure. (source)
- In a placebo-controlled human clinical trial, the Scottsdale Magnesium Study, Jigsaw Heath MagSRT® was shown to decrease blood pressure by 11%. (source)
- Magnesium is an essential electrolyte that must be obtained from food (leafy greens, almonds, etc.) and/or magnesium supplements, such as Jigsaw Health MagSRT®. (source)
- The CDC estimates that 45% of Americans (116 million) have high blood pressure. (source)
- Other than measuring your blood pressure, there are generally no physical signs of high blood pressure -- the American Heart Association refers to high blood pressure as a "symptomless, silent killer.” (source)
- Left untreated, high blood pressure can lead to stroke, heart attack, and other health problems. (source)
- Prescription blood pressure medications have a number of unwanted side effects, including weakness, leg cramps, and fatigue. (source)
- If you've been using Jigsaw MagSRT to manage your blood pressure, we'd love to hear from you! Please email firstname.lastname@example.org and share your story with us.
More details and links to sources are included throughout the rest of the story below...
On Monday January 10, 2022, an historic announcement was made: FDA will now allow certain qualified health claims for Magnesium and High Blood Pressure. #KABOOM 😮
More specifically, FDA stated they will now allow the following statement to be used on the labels (or in the labeling of) conventional foods and dietary supplements containing magnesium:
“Supportive but inconclusive scientific evidence suggests that diets with adequate magnesium may reduce the risk of high blood pressure (hypertension), a condition associated with many factors.”
We at Jigsaw Health have conclusive data that we'd like to share with you...
But first, major KUDOS and MAHALO to Hawaii-based Andrea Rosanoff, Ph.D., the Director of the Center for Magnesium Education & Research. Her team has been submitting data to the FDA since October 2016 to make this claim possible.
Back to the good news...
During the Scottsdale Magnesium Study (2017-2019), researchers (Weiss, Brunk, and Goodman) discovered that Jigsaw Heath MagSRT® decreased Systolic Blood Pressure (SBP) by 11% over 90 days in individuals with untreated, Stage 1 Hypertension.
SBP dropped from 145 to 129; this difference was significant compared to a placebo group.
Furthermore, 30 days after MagSRT® supplementation ended, both systolic and diastolic blood pressure reverted to baseline values; SBP went back up from 129 to 144.
The research team submitted these findings to the American Heart Association in April 2019. But in August 2019, the paper was rejected with the following explanation:
“The number of abstracts submitted continues to grow substantially, and unfortunately, many good papers could not be included in the program. We hope this does not discourage you from future submissions and we hope to see you [at the conference] in Philadelphia.”
At that time, we chose not to publish this blood pressure data because – on the advice of regulatory counsel – we were concerned that even though we had good data, the FDA may penalize us for attempting to make a “drug claim” for Jigsaw MagSRT. Because, as a matter of regulatory definition, dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. And hypertension is considered a disease.
Ironically enough, in early 2019, prior to submitting the paper to AHA, we shared our MagSRT blood pressure findings with Dr. Rosanoff. Her team was impressed, stating:
“[The Scottsdale Magnesium Study] certainly matches what we found – effective on high BP people, but doesn’t affect those with lower BP. Striking that BP goes right back up when the supplementation was stopped!”
Prescription blood pressure medications have a number of unwanted side effects, including weakness, leg cramps, and fatigue. (Source: WebMD)
As long-time advocates of Magnesium and it's many benefits to overall health, we at Jigsaw Health are thrilled that patients and their doctors now have a clinically tested magnesium supplement to consider for managing blood pressure, without the unwanted side effects of prescription blood pressure medications.
Jigsaw Health will continue to help lead the charge in educating the public and physicians that MagSRT® is a smart choice.
As Maya Angelou said, “Do the best you can until you know better. Then when you know better, do better."
PS - If you've been using Jigsaw MagSRT to control your blood pressure, we'd love to hear from you! Please email email@example.com and share your story with us. :)
Links to related stories:
- FDA approves qualified claim for magnesium and blood pressure
- FDA will allow qualified health claims for magnesium and reduced risk of high blood pressure
- PUBMED: Oral magnesium supplements decrease high blood pressure (SBP>155 mmHg) in hypertensive subjects on anti-hypertensive medications: a targeted meta-analysis (Rosanoff & Plesset)
- Scottsdale Magnesium Study